Taku K - Search Results

1

Phase II study of S-1 plus oxaliplatin 130 mg/m² in Japanese patients with advanced gastric cancer.

Kito Y, Machida N, Kawai S, Hamauchi S, Tsushima T, Todaka A, Yokota T, Yamazaki K, Fukutomi A, Onozawa Y, Tsuji K, Doyama H, Haraguchi Y, Nakashima K, Kunieda K, Taku K, Mori K, Yasui H. Kito Y, et al. Among authors: taku k. Int J Clin Oncol. 2018 Dec;23(6):1084-1089. doi: 10.1007/s10147-018-1308-1. Epub 2018 Jun 21. Int J Clin Oncol. 2018. PMID: 29931597 Clinical Trial.

2

Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer.

Machida N, Yoshino T, Boku N, Hironaka S, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Asaka M. Machida N, et al. Among authors: taku k. Jpn J Clin Oncol. 2008 Oct;38(10):689-94. doi: 10.1093/jjco/hyn086. Jpn J Clin Oncol. 2008. PMID: 18845522

3

Irinotecan plus cisplatin therapy and S-1 plus cisplatin therapy for advanced or recurrent gastric cancer in a single institution.

Nakashima K, Hironaka S, Boku N, Onozawa Y, Fukutomi A, Yamazaki K, Yasui H, Taku K, Kojima T, Machida N. Nakashima K, et al. Among authors: taku k. Jpn J Clin Oncol. 2008 Dec;38(12):810-5. doi: 10.1093/jjco/hyn109. Epub 2008 Nov 6. Jpn J Clin Oncol. 2008. PMID: 18988666

4

Activity of S-1 in advanced or recurrent gastric cancer patients after failure of prior chemotherapy, including irinotecan + cisplatin or fluorouracil (except S-1).

Ono A, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yasui H, Yamazaki K, Yoshino T, Taku K, Kojima T. Ono A, et al. Among authors: taku k. Jpn J Clin Oncol. 2009 May;39(5):332-5. doi: 10.1093/jjco/hyp018. Epub 2009 Mar 24. Jpn J Clin Oncol. 2009. PMID: 19318372

5

Retrospective analysis of S-1 monotherapy in patients with metastatic colorectal cancer after failure to fluoropyrimidine and irinotecan or to fluoropyrimidine, irinotecan and oxaliplatin.

Yasui H, Yoshino T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Kojima T, Machida N. Yasui H, et al. Among authors: taku k. Jpn J Clin Oncol. 2009 May;39(5):315-20. doi: 10.1093/jjco/hyp014. Jpn J Clin Oncol. 2009. PMID: 19403734

6

Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination.

Imazawa M, Kojima T, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yasui H, Yamazaki K, Taku K. Imazawa M, et al. Among authors: taku k. Gastric Cancer. 2009;12(3):153-7. doi: 10.1007/s10120-009-0517-8. Epub 2009 Nov 5. Gastric Cancer. 2009. PMID: 19890695

7

Safety of bevacizumab treatment in combination with standard chemotherapy for metastatic colorectal cancer: a retrospective review of 65 Japanese patients.

Tamiya A, Yamazaki K, Boku N, Machida N, Kojima T, Taku K, Yasui H, Fukutomi A, Hironaka S, Onozawa Y. Tamiya A, et al. Among authors: taku k. Int J Clin Oncol. 2009 Dec;14(6):513-7. doi: 10.1007/s10147-009-0911-6. Epub 2009 Dec 5. Int J Clin Oncol. 2009. PMID: 19967487

8

Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin.

Shimoyama R, Yasui H, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Kojima T, Machida N, Todaka A, Tomita H, Sakamoto T, Tsushima T. Shimoyama R, et al. Among authors: taku k. Gastric Cancer. 2009;12(4):206-11. doi: 10.1007/s10120-009-0524-9. Epub 2010 Jan 5. Gastric Cancer. 2009. PMID: 20047125

9

S-1 monotherapy as second-line treatment for advanced pancreatic cancer after gemcitabine failure.

Todaka A, Fukutomi A, Boku N, Onozawa Y, Hironaka S, Yasui H, Yamazaki K, Taku K, Machida N, Sakamoto T, Tomita H. Todaka A, et al. Among authors: taku k. Jpn J Clin Oncol. 2010 Jun;40(6):567-72. doi: 10.1093/jjco/hyq005. Epub 2010 Feb 26. Jpn J Clin Oncol. 2010. PMID: 20189975

10

Comparison of combination chemotherapy with irinotecan and cisplatin regimen administered every 2 or 4 weeks in pretreated patients with unresectable or recurrent gastric cancer: retrospective analysis.

Sakamoto T, Yasui H, Boku N, Onozawa Y, Hironaka S, Fukutomi A, Yamazaki K, Taku K, Machida N, Todaka A, Tomita H, Tsushima T, Taniguchi H, Hamauchi S. Sakamoto T, et al. Among authors: taku k. Int J Clin Oncol. 2010 Jun;15(3):287-93. doi: 10.1007/s10147-010-0054-9. Epub 2010 Mar 10. Int J Clin Oncol. 2010. PMID: 20217447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters